Israel Englander Adaptimmune Therapeutics PLC Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Millennium Management LLC holds 779,615 shares of ADAP stock, worth $779,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
779,615
Previous 825,179
5.52%
Holding current value
$779,615
Previous $1.3 Million
41.37%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ADAP
# of Institutions
81Shares Held
152MCall Options Held
78.5KPut Options Held
36.5K-
Matrix Capital Management Company, LP Waltham, MA39MShares$39 Million0.29% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$27.4 Million0.95% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$17.1 Million1.58% of portfolio
-
Baillie Gifford & CO15.1MShares$15.1 Million0.01% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR12.3MShares$12.3 Million0.49% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $163M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...